ADCT

Neutral

ADC Therapeutics launches restructuring around ZYNLONTA

ADC Therapeutics (NYSE:ADCT) is undergoing a strategic reorganization focusing on its ZYNLONTA franchise and related clinical trials. The restructurin...

grafa.com 22 hours ago 0

Bearish

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

Pomerantz LLP is investigating potential securities fraud claims against ADC Therapeutics SA (ADCT) on behalf of investors. This investigation follows...

PR Newswire 1 week ago 0

Bearish

ADC Therapeutics falls on confirmatory trial data for lymphoma therapy

ADC Therapeutics (ADCT) shares fell following the announcement of confirmatory Phase 3 trial data for their lymphoma therapy, ZYNLONTA, at the ASCO an...

MSN 2 weeks ago 0